Trial Profile
Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of the COMIRNATY vaccine (COVID-19 mRNA vaccine, Pfizer-BioNTech) in people with long COVID
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2021
Price :
$35
*
At a glance
- Drugs Tozinameran (Primary)
- Indications Post acute COVID 19 syndrome
- Focus Therapeutic Use
- 09 Aug 2021 New trial record